The calf model of immunity for development of a vaccine against tuberculosis

Veterinary Immunology and Immunopathology

Volumn 128, Issue 1-3, 2009, Pages 199-204

  Endsley, Janice J ^b   Waters, W Ray ^a   Palmer, Mitchell V ^a   Nonnecke, Brian J ^a   Thacker, Tyler C ^a   Jacobs Jr , William R ^c   Larsen, Michelle H ^c   Hogg, Alison ^b   Shell, Elisabeth ^b   McAlauy, Martin ^d   Scherer, Charles F Capinosh ^b   Coffey, Tracey ^d   Howard, Chris J ^d   Villareal Ramos, Bernardo ^d   Estes, D Mark ^b  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

markers; neonatal calf; prognostic; Tuberculosis

Indexed keywords

B7 ANTIGEN; BCG VACCINE; CD86 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; PROTEIN ESAT 6:CFP10; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ARTICLE; CATTLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; NONHUMAN; PROGNOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOCYTES; MYCOBACTERIUM BOVIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, BOVINE; TUBERCULOSIS, PULMONARY;

ANIMALIA; BOVINAE; HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM BOVIS BCG; PRIMATES; RODENTIA;

EID: 60549111022     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.312     Document Type: Article

References (46)

1. Buddle B.M., Ryan T.J., et al. Use of ESAT-6 in the interferon-gamma test for diagnosis of bovine tuberculosis following skin testing. Vet. Microbiol. 80 1 (2001) 37-46
2. Buddle B.M., Skinner M.A., et al. Cattle as a model for development of vaccines against human tuberculosis. Tubercle (Edinb.) 85 1-2 (2005) 19-24
3. Buddle B.M., Wedlock D.N., Parlane N.A., Corner L.A., De Lisle G.M., and Skinner M.A. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect. Immun. 71 11 (2003) 6411-6419
4. Calmette A. Preventive vaccination against tuberculosis with BCG. Proc. R. Soc. Med. 24 11 (1931) 1481-1490
5. Carpenter E., Fray L., et al. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes. Immunol. Cell Biol. 75 6 (1997) 554-560
6. Cassidy J.P., Bryson D.G., et al. Lymphocyte subtypes in experimentally induced early-stage bovine tuberculous lesions. J. Comp. Pathol. 124 1 (2001) 46-51
7. Centers for Disease Control and P., 2005. Human tuberculosis caused by Mycobacterium bovis-New York City, 2001-2004. MMWR-Morbidity & Mortality Weekly Report 54(24): 605-608.
8. Cho S., Mehra V., et al. Antimicrobial activity of MHC class I-restricted CD8 +T cells in human tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 97 22 (2000) 12210-12215
9. Cleaveland S., Haydon D.T., et al. Overviews of pathogen emergence: which pathogens emerge when and why?. Curr. Topics Microbiol. Immunol. 315 (2007) 85-111
10. Dieli F., Troye-Blomberg M., et al. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J. Infect. Dis. 184 8 (2001) 1082-1085
11. Endsley J.J., Endsley M.A., et al. Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. J. Leukoc. Biol. 79 1 (2006) 71-79
12. Endsley J.J., Furrer J.L., et al. Characterization of bovine homologues of Granulysin and NK-lysin. J. Immunol. 173 4 (2004) 2607-2614
13. Endsley J.J., Hogg A., et al. Mycobacterium bovis BCG vaccination induces memory CD4(+) T cells characterized by effector biomarker expression and anti-mycobacterial activity. Vaccine 25 50 (2007) 8384-8394
14. Flynn J.L. Immunology of tuberculosis and implications in vaccine development. Tubercle (Edinb.) 84 1-2 (2004) 93-101
15. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
16. Foote M.R., Nonnecke B.J., et al. High growth rate fails to enhance adaptive immune responses of neonatal calves and is associated with reduced lymphocyte viability. J. Dairy Sci. 90 1 (2007) 404-417
17. Hogarth P.J., Hewinson R.G., et al. Development of vaccines against bovine tuberculosis. J. Pharm. Pharmacol. 58 6 (2006) 749-757
18. Hope J.C., Sopp P., et al. NK-like CD8(+) cells in immunologically naive neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG. J. Leukoc. Biol. 71 2 (2002) 184-194
19. Hope J.C., Thom M.L., et al. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis [erratum appears in Clin. Exp. Immunol. 2005 April;140(1):192]. Clin. Exp. Immunol. 139 1 (2005) 48-56
20. Junqueira-Kipnis A.P., Kipnis A., et al. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J. Immunol. 171 11 (2003) 6039-6045
21. Kaufmann S.H. Is the development of a new tuberculosis vaccine possible?. Nat. Med. 6 9 (2000) 955-960
22. Kulberg S., Boysen P., et al. Reference values for relative numbers of natural killer cells in cattle blood. Dev. Comp. Immunol. 28 9 (2004) 941-948
23. Leonard W.J., and Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5 9 (2005) 688-698
24. Liebana E., Aranaz A., et al. Cellular interactions in bovine tuberculosis: release of active mycobacteria from infected macrophages by antigen-stimulated T cells. Immunology 99 1 (2000) 23-29
25. Maue A.C., Waters W.R., et al. CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis. Vaccine 23 6 (2004) 769-779
26. Maue A.C., Waters W.R., et al. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 25 24 (2007) 4735-4746
27. Nonnecke B.J., Waters W.R., et al. Development of an adult-like cell-mediated immune response in calves after early vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J. Dairy Sci. 88 1 (2005) 195-210
28. Palmer M.V., Waters W.R., et al. Aerosol delivery of virulent Mycobacterium bovis to cattle. Tubercle 82 6 (2002) 275-282
29. Pollock J., McNair M.J., et al. Immune responses in bovine tuberculosis. Tubercle (Edinb.) 81 1-2 (2001) 103-107
30. Pollock J.M., Welsh M.D., et al. Immune responses in bovine tuberculosis: towards new strategies for the diagnosis and control of disease. Vet. Immunol. Immunopathol. 108 1-2 (2005) 37-43
31. Rhoades E.R., Frank A.A., et al. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78 1 (1997) 57-66
32. Rodgers J.D., Connery N.L., et al. Experimental exposure of cattle to a precise aerosolised challenge of Mycobacterium bovis: a novel model to study bovine tuberculosis. Tubercle 87 5 (2007) 405-414
33. Rook G.A., Dheda W.K., et al. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol. 5 8 (2005) 661-667
34. Smith R.A., Kreeger J.M., et al. Role of CD8(+) and WC-1(+) gamma/delta T cells in resistance to Mycobacterium bovis infection in the SCID-bo mouse. J. Leukoc. Biol. 65 1 (1999) 28-34
35. Stenger S. Cytolytic T cells in the immune response to Mycobacterium tuberculosis. Scand J. Infect. Dis. 33 7 (2001) 483-487
36. Stenger S., Hanson D.A., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282 5386 (1998) 121-125
37. Stenger S., Mazzaccaro R.J., et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276 5319 (1997) 1684-1687
38. Storset A.K., Kulberg S., et al. NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics. Eur. J. Immunol. 34 3 (2004) 669-676
39. Storset A.K., Slettedal I.O., et al. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs. Eur. J. Immunol. 33 4 (2003) 980-990
40. Villarreal-Ramos B., McAulay M., et al. Investigation of the role of CD8 +T cells in bovine tuberculosis in vivo. Infect. Immun. 71 8 (2003) 4297-4303
41. Vordermeier H.M., Chambers M.A., et al. Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle [see comment]. Vet. J. 171 2 (2006) 229-244
42. Walsh G.P., Tan E.V., et al. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat. Med. 2 4 (1996) 430-436
43. Wangoo A., Johnson L., et al. Advanced granulomatous lesions in Mycobacterium bovis-infected cattle are associated with increased expression of type I procollagen, gammadelta (WC1+) T cells and CD 68 + cells. J. Comp. Pathol. 133 4 (2005) 223-234
44. Waters W.R., Nonnecke B.J., et al. Mycobacterium bovis bacille Calmette-Guerin vaccination of cattle: activation of bovine CD4+ and gamma delta TCR + cells and modulation by 1 25-dihydroxyvitamin D3. Tubercle 83 5 (2003) 287-297
45. Waters W.R., Palmer M.V., et al. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin. Vaccine 25 45 (2007) 7832-7840
46. Widdison S., Schreuder L.J., et al. Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guerin vaccination. Clin. Exp. Immunol. 144 2 (2006) 281-289